In the first bellwether product liability trial regarding the blood thinner Xarelto a New Orleans jury has ruled in favor of Johnson & Johnson and Bayer. Although this is not a favorable decision for the plaintiff, those bringing future lawsuits should not panic. The lawsuit was brought by Louisiana resident…
An antidepressant drug Paxil related suicide lawsuit resulted in a multimillion dollar verdict in favor of the plaintiff. In late April, a Chicago jury awarded widow Wendy Dolin $3 Million in her lawsuit against GlaxoSmithKline, the British pharmaceutical company and developer of the antidepressant Paxil. Dolin brought the claim against…
Xarelto (rivaroxaban) is commonly marketed in the United States as a blood-thinner generally prescribed to combat blood clots. Although, the serious nature of the side effects caused by Xarelto are leading to a staggering number of lawsuits. Current and former users and their families are claiming that the risks and…
In 2010, the U.S. Food and Drug Administration (FDA) approve the blood thinner Pradaxa. Pradaxa was used by patients to prevent blood clots from forming due to the individual’s irregular heart rhythm (atrial fibrillation). The drug was produced by German manufacturer Boehringer Ingelheim Pharmaceuticals as a substitute to the drug…
A staggering number of families have made claims against the drug manufacturing company GlaxoSmithKline. These claims are centered around GlaxoSmithKline’s drug Zofran (the generic form of which is named ondansetron and is commonly used to prevent nausea, vomiting and other sicknesses in cancer patients during various cancer surgeries, chemotherapy and…